Intensity Modulated Radiation Therapy

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer

Surgery Followed by Risk-Directed Post-Operative Adjuvant Therapy for HPV-Related Oropharynx Squamous Cell Carcinoma: "The Minimalist Trial (MINT)"

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer

Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma

Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Efficacy of Ulinastatin for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients

Phase II Trial Evaluating Elimination of Radiation Therapy

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

Pembrolizumab + Radiation for Locally Adv SCC of the Head and Neck (SCCHN) Not Eligible Cisplatin

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer

Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer

Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 Trial